| scholarly article | Q13442814 |
| P50 | author | START Trialists' Group | Q114413301 |
| Joanne Haviland | Q42791326 | ||
| Peter Barrett-Lee | Q56446934 | ||
| David Morgan | Q64021961 | ||
| P2093 | author name string | J Brown | |
| S Simmons | |||
| R K Agrawal | |||
| J Mills | |||
| J R Yarnold | |||
| P J Hoskin | |||
| J M Bliss | |||
| S M Bentzen | |||
| B J Magee | |||
| E G A Aird | |||
| G Sumo | |||
| H J Dobbs | |||
| J A Dewar | |||
| J M Barrett | |||
| J R Owen | |||
| K Venables | |||
| M A Sydenham | |||
| P A Lawton | |||
| P Hopwood | |||
| P2860 | cites work | The RAGE litigation. Radiation Action Group Exposure | Q74757126 |
| Outcome of radiotherapy after breast conserving surgery in screen detected breast cancers | Q77294562 | ||
| The use of in vivo thermoluminescent dosimeters in the quality assurance programme for the START breast fractionation trial | Q80149557 | ||
| What is the optimum breast plan: a study based on the START trial plans | Q80184935 | ||
| Verification films: a study of the daily and weekly reproducibility of breast patient set-up in the START trial | Q81053588 | ||
| The hospital anxiety and depression scale | Q27860968 | ||
| Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials | Q29031162 | ||
| The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology | Q29615701 | ||
| Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer? | Q33603495 | ||
| Calculating the number needed to treat for trials where the outcome is time to an event | Q33785536 | ||
| A shorter fractionation schedule for postlumpectomy breast cancer patients | Q33964210 | ||
| Local recurrence of breast cancer following surgery and radiotherapy: incidence and outcome | Q35071917 | ||
| The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial | Q36571627 | ||
| The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study | Q40925956 | ||
| Fears over radiotherapy fractionation regimens in breast cancer. Proposed Uk trial needs to define techniques as well as numbers of treatments | Q42757647 | ||
| Radiotherapy after breast-preserving surgery in women with localized cancer of the breast | Q44124275 | ||
| Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer | Q44230659 | ||
| Inappropriate use of linear-quadratic analysis of tumor response | Q45000466 | ||
| Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer | Q45041163 | ||
| Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial | Q47335209 | ||
| National survey of radiotherapy fractionation practice in 2003. | Q48650507 | ||
| Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. | Q50760966 | ||
| The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). | Q50912398 | ||
| Three-dimensional distribution of radiation within the breast: an intercomparison of departments participating in the START trial of breast radiotherapy fractionation. | Q52025609 | ||
| The START trial-measurements in semi-anatomical breast and chest wall phantoms. | Q52058201 | ||
| The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. | Q52428164 | ||
| A body image scale for use with cancer patients | Q61775185 | ||
| Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial | Q68201092 | ||
| Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation | Q69884400 | ||
| Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group | Q71807931 | ||
| Late cosmetic results of short fractionation for breast conservation | Q71877343 | ||
| Seven-year follow-up on 334 patients treated by breast conserving surgery and short course radical postoperative radiotherapy: a report of the Yorkshire Breast Cancer Group | Q71910013 | ||
| Carcinoma of the breast. Stage II--radiation range. Wedge resection and irradiation. An effective treatment in early breast cancer | Q72344518 | ||
| Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer | Q72733504 | ||
| Breast radiotherapy phantom design for the START trial. START trial management group | Q73506443 | ||
| A survey of radiotherapy quality control practice in the United Kingdom for the START trial | Q74403107 | ||
| P433 | issue | 9618 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| adaptive radiation therapy | Q180507 | ||
| P304 | page(s) | 1098-1107 | |
| P577 | publication date | 2008-03-19 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial | |
| P478 | volume | 371 |
| Q26824593 | Q26824593 |
| Q47103076 | 21-gene recurrence assay in patients receiving intraoperative radiotherapy: are “favorable” characteristics a surrogate for low recurrence? |
| Q98292842 | A Canadian Response to the Coronavirus Disease 2019 (COVID-19) Pandemic: Is There a Silver Lining for Radiation Oncology Patients? |
| Q36993295 | A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer |
| Q49590443 | A Comparative Study of Hypofractionated and Conventional Radiotherapy in Postmastectomy Breast Cancer Patients |
| Q34408374 | A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects |
| Q36303421 | A planning comparison of 7 irradiation options allowed in RTOG 1005 for early-stage breast cancer |
| Q38203301 | A review of clinical aspects of breast cancer |
| Q37905913 | ACR Appropriateness Criteria® conservative surgery and radiation--stage I and II breast carcinoma: expert panel on radiation oncology: breast |
| Q30318240 | AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011. |
| Q37947886 | Abbreviated course of radiotherapy (RT) for breast cancer |
| Q35971581 | Accelerated Partial Breast Irradiation: Using the CyberKnife as the Radiation Delivery Platform in the Treatment of Early Breast Cancer |
| Q46028849 | Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients. |
| Q33723980 | Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years |
| Q35797762 | Accelerated partial breast irradiation using once-daily fractionation: analysis of 312 cases with four years median follow-up |
| Q84624972 | Accelerated partial breast irradiation: bifractionated 40Gy in one week. A French pilot phase II study |
| Q44109932 | Accelerated partial breast irradiation: potential roles following breast-conserving surgery |
| Q61454334 | Accelerated partial breast radiotherapy: a review of the literature and future directions |
| Q33662782 | Acute radiation dermatitis in breast cancer patients: challenges and solutions |
| Q34520010 | Adjuvant chemotherapy and acute toxicity in hypofractionated radiotherapy for early breast cancer |
| Q35051256 | Adjuvant therapy for women over age 65 with breast cancer |
| Q28066744 | Adjuvant treatment for older women with invasive breast cancer |
| Q38997213 | Age-related Disparity: Breast Cancer in the Elderly |
| Q24186971 | Altered radiation fractionation schedules for clinically localised and locally advanced prostate cancer |
| Q35874123 | An update in breast cancer screening and management. |
| Q84143794 | Are Three Weeks of Whole-Breast Radiotherapy as Good as Five Weeks in Early Breast Cancer? - 10 Year Follow-Up in the Canadian Trial of Hypofractionated Radiation Therapy |
| Q35356286 | Assessment of contralateral mammary gland dose in the treatment of breast cancer using accelerated hypofractionated radiotherapy |
| Q42571014 | At last, a predictive and prognostic marker for radiotherapy? |
| Q35588667 | Audit of local recurrence following breast conservation surgery with 5-mm target margin and hypofractionated 40-Gray breast radiotherapy for invasive breast cancer |
| Q33887892 | Biological dosimetry for breast cancer radiotherapy: a comparison of external beam and intraoperative radiotherapy |
| Q43775129 | Biologically effective dose and breast cancer conservative treatment: is duration of radiation therapy really important? |
| Q34203340 | Boost IORT in Breast Cancer: Body of Evidence |
| Q40854023 | Breast Cancer Patients' Preferences for Adjuvant Radiotherapy Post Lumpectomy: Whole Breast Irradiation vs. Partial Breast Irradiation-Single Institutional Study |
| Q36826596 | Breast Cancer in the Bahamas in 2009-2011. |
| Q38148495 | Breast cancer management in the elderly |
| Q33751802 | Breast cancer: Actual methods of treatment and future trends |
| Q40429171 | Breast interest group faculty of radiation oncology: Australian and New Zealand patterns of practice survey on breast radiotherapy |
| Q64957300 | Breast-conserving radiotherapy with simultaneous integrated boost; field-in-field three-dimensional conformal radiotherapy versus inverse intensity-modulated radiotherapy - A dosimetric comparison: Do we need intensity-modulated radiotherapy? |
| Q37287532 | Can cutaneous telangiectasiae as late normal-tissue injury predict cardiovascular disease in women receiving radiotherapy for breast cancer? |
| Q64076911 | Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial |
| Q64076881 | Cardiac Structure Doses in Women Irradiated for Breast Cancer in the Past and Their Use in Epidemiological Studies |
| Q49976435 | Changes in radiotherapy fractionation - breast cancer. |
| Q49493403 | Choosing wisely after publication of level I evidence in breast cancer radiotherapy |
| Q36619141 | Clinical analysis of intraoperative radiotherapy during breast-conserving surgery of early breast cancer in the Chinese Han population. |
| Q37422274 | Clinical relevance of radiation pneumonitis in breast cancers |
| Q92735116 | Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review |
| Q91845092 | Comparison of Toxicity and Cosmetic Outcomes After Accelerated Partial Breast Irradiation or Whole Breast Irradiation Using 3-Dimensional Conformal External Beam Radiation Therapy |
| Q51827094 | Comparison of fractionation schedules in the large heterogeneity limit. |
| Q50912422 | Comparison of hypofractionated and conventionally fractionated whole-breast irradiation for early breast cancer patients: a single-institute study of 1,098 patients. |
| Q48890409 | Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials |
| Q39565830 | Comparison of two radiation techniques for the breast boost in patients undergoing neoadjuvant treatment for breast cancer |
| Q90698873 | Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity |
| Q55013955 | Cosmesis after early stage breast cancer treatment with surgery and radiation therapy: experience of patients treated in a Chilean radiotherapy centre. |
| Q44553996 | Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer |
| Q37533025 | Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer |
| Q28972351 | Current role of modern radiotherapy techniques in the management of breast cancer |
| Q37301839 | DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer |
| Q57113701 | De-escalation of breast radiotherapy after conserving surgery in low-risk early breast cancer patients |
| Q40206579 | Decision to adopt medical technology: case study of breast cancer radiotherapy techniques. |
| Q83180899 | Dosimetric evaluation of whole breast radiotherapy using field-in-field technique in early-stage breast cancer |
| Q38790919 | Dosimetric trade-offs in breast treatment with VMAT technique |
| Q85173921 | Early Side Effects of Three-Dimensional Conformal External Beam Accelerated Partial Breast Irradiation to a Total Dose of 40 Gy in One Week (A Phase II Trial) |
| Q33804575 | Early invasive cancer and partial intraoperative electron radiation therapy of the breast: experience of the jules bordet institute |
| Q84854563 | Early stage breast cancer and radiotherapy: update |
| Q26782584 | Early-Stage Breast Cancer in the Elderly: Confronting an Old Clinical Problem |
| Q57304436 | Economic Cost of Treating Older Adults with Cancer |
| Q84965996 | Effect of radiotherapy boost and hypofractionation on outcomes in ductal carcinoma in situ |
| Q37355495 | Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial |
| Q26774616 | Emerging Role of Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Modern Radiotherapy of Breast Cancer |
| Q37898113 | Emerging radiation techniques for early-stage breast cancer after breast-conserving surgery |
| Q96225251 | Ensuring Safety and Sustainability of Radiotherapy Services during the COVID-19 Pandemic in Resources Constrain Country: An Indonesian Experience |
| Q84624967 | Evaluation of immediate breast reconstruction and radiotherapy: factors associated with complications |
| Q33643750 | Evidence from a breast cancer hypofractionated schedule: late skin toxicity assessed by ultrasound. |
| Q39006101 | External radiotherapy for breast cancer in the elderly |
| Q55083651 | Factors affecting radiotherapy prescribing patterns in the post-mastectomy setting. |
| Q41037341 | Factors associated with radiation therapy incompletion for patients with early-stage breast cancer |
| Q34316748 | Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy |
| Q89478951 | Feasibility of Breast-Conservation Therapy and Hypofractionated Radiation in the Setting of Prior Breast Augmentation |
| Q57795867 | Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma |
| Q33383943 | Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer |
| Q36166224 | Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer |
| Q44057851 | Five-year results of a prospective case series of accelerated hypofractionated whole breast radiation with concomitant boost to the surgical bed after conserving surgery for early breast cancer |
| Q47368780 | Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration. |
| Q37176814 | Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer |
| Q26471067 | Fraction size in radiation therapy for breast conservation in early breast cancer |
| Q24236396 | Fraction size in radiation treatment for breast conservation in early breast cancer |
| Q42388957 | Future of translational research: Why go pragmatic? |
| Q38912981 | Geographic Disparity in the Use of Hypofractionated Radiation Therapy Among Elderly Women Undergoing Breast Conservation for Invasive Breast Cancer |
| Q36228114 | Guidelines for locoregional therapy in primary breast cancer in developing countries: The results of an expert panel at the 8(th) Annual Women's Cancer Initiative - Tata Memorial Hospital (WCI-TMH) Conference |
| Q34457957 | Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy. |
| Q33688952 | Hitting the right spot |
| Q92327769 | Hydrofilm Polyurethane Films Reduce Radiation Dermatitis Severity in Hypofractionated Whole-Breast Irradiation: An Objective, Intra-Patient Randomized Dual-Center Assessment |
| Q57397738 | Hypofractionated Adjuvant Whole Breast Radiotherapy: Progress and Prospects |
| Q38811255 | Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial |
| Q89967125 | Hypofractionated Radiotherapy Dose Scheme and Application of New Techniques Are Associated to a Lower Incidence of Radiation Pneumonitis in Breast Cancer Patients |
| Q34171934 | Hypofractionated Radiotherapy and Adjuvant Chemotherapy Do Not Increase Radiation-Induced Dermatitis in Breast Cancer Patients |
| Q26776288 | Hypofractionated Radiotherapy as Adjuvant Treatment in Early Breast Cancer. A Review and Meta-Analysis of Randomized Controlled Trials |
| Q86065565 | Hypofractionated breast radiation: preferred standard of care? |
| Q96682566 | Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial |
| Q36010013 | Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases |
| Q37954519 | Hypofractionated radiation therapy in the treatment of early-stage breast cancer |
| Q57108643 | Hypofractionated radiation treatment in the management of breast cancer |
| Q34397964 | Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity |
| Q33957583 | Hypofractionated radiotherapy for breast cancer acceleration of the START A treatment regime: intermediate tolerance and efficacy |
| Q37392231 | Hypofractionated radiotherapy for early breast cancer: Review of phase III studies |
| Q38863898 | Hypofractionated radiotherapy for organ-confined prostate cancer: is less more? |
| Q39292764 | Hypofractionated radiotherapy has the potential for second cancer reduction |
| Q34391739 | Hypofractionated radiotherapy in the treatment of early breast cancer |
| Q93104828 | Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study |
| Q91317243 | Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial |
| Q39712338 | Hypofractionated versus conventionally fractionated radiotherapy for ductal carcinoma in situ (DCIS) of the breast |
| Q26745834 | Hypofractionated whole breast irradiation: new standard in early breast cancer after breast-conserving surgery |
| Q36270554 | Hypofractionated whole breast radiotherapy in breast conservation for early-stage breast cancer: a systematic review and meta-analysis of randomized trials. |
| Q64882416 | Hypofractionation Radiotherapy vs. Conventional Fractionation for Breast Cancer: A Comparative Review of Toxicity. |
| Q47362487 | Hypofractionation does not increase radiation pneumonitis risk with modern conformal radiation delivery techniques. |
| Q97073372 | Hypofractionation in COVID-19 Radiotherapy: A Mix of Evidence Based Medicine and of Opportunities |
| Q46699336 | Hypofractionation in post-mastectomy breast cancer patients: seven-year follow-up |
| Q57338044 | Hypofractionation with simultaneous integrated boost for early breast cancer |
| Q39768456 | Identifying gaps in the locoregional management of early breast cancer: highlights from the Kyoto Consensus Conference. |
| Q37139905 | Impact of hypofractionation and tangential beam IMRT on the acute skin reaction in adjuvant breast cancer radiotherapy. |
| Q57113676 | Implementation and utilization of hypofractionation for breast cancer |
| Q38757873 | Improving efficacy and efficiency through the implementation of a new organisational model in a Radiation Oncology Department |
| Q91989214 | Individualised target volume selection and dose prescription after conservative surgery, mastectomy and reconstruction |
| Q64063435 | Influence of Radiation Dose to Reconstructed Breast Following Mastectomy on Complication in Breast Cancer Patients Undergoing Two-Stage Prosthetic Breast Reconstruction |
| Q36002221 | Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/ II breast carcinoma |
| Q84903898 | Innovations in radiation therapy (RT) for breast cancer |
| Q86870339 | Intensity-modulated and hypofractionated simultaneous integrated boost adjuvant breast radiation employing statics ports of tomotherapy (TomoDirect): a prospective phase II trial |
| Q90470904 | Intensity-modulated radiotherapy and hypofractionated volumetric modulated arc therapy for elderly patients with breast cancer: comparison of acute and late toxicities |
| Q60050114 | Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Adva |
| Q57110198 | Intraoperative Electron Radiotherapy (IOERT) in the Treatment of Primary Breast Cancer |
| Q38193576 | Intraoperative radiation therapy techniques and options for breast cancer |
| Q37593615 | Intraoperative radiotherapy (IORT) as boost in breast cancer. |
| Q57397740 | Intraoperative radiotherapy for early breast cancer |
| Q38383207 | Intraoperative radiotherapy in early breast cancer |
| Q92901350 | Ipsilateral breast tumor recurrence in early stage breast cancer patients treated with breast conserving surgery and adjuvant radiation therapy: Concordance of biomarkers and tumor location from primary tumor to in-breast tumor recurrence |
| Q35976168 | Late Toxicity of Radiotherapy: A Problem or a Challenge for the Radiation Oncologist? |
| Q57397723 | Late effects of breast radiotherapy |
| Q49218612 | Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials. |
| Q49109112 | Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A. |
| Q39481284 | Less increase of CT-based calcium scores of the coronary arteries : Effect three years after breast-conserving radiotherapy using breath-hold |
| Q37126030 | Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer |
| Q39010721 | Loco-regional morbidity after breast conservation and axillary lymph node dissection for early breast cancer with or without regional nodes radiotherapy, perspectives in modern breast cancer treatment: the Skagen Trial 1 is active |
| Q37678304 | Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel |
| Q43818331 | Long-term outcome of hypofractionated radiotherapy to the whole breast of Japanese women after breast-conserving surgery |
| Q37061962 | Lung dose analysis in loco-regional hypofractionated radiotherapy of breast cancer |
| Q36365514 | Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? |
| Q36755872 | Management of breast cancer--part I. |
| Q37999119 | Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). |
| Q38350939 | Management of locally advanced breast cancer-perspectives and future directions |
| Q38254650 | Management of operable primary breast cancer in older women |
| Q47270683 | Mathematical Modeling of the Effects of Tumor Heterogeneity on the Efficiency of Radiation Treatment Schedule |
| Q34384919 | Measurement of mean cardiac dose for various breast irradiation techniques and corresponding risk of major cardiovascular event |
| Q41705329 | Milestones in breast cancer treatment |
| Q35061078 | No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: results from the RAPPER study |
| Q41601769 | Normal Tissue Complications following Hypofractionated Chest Wall Radiotherapy in Breast Cancer Patients and Their Correlation with Patient, Tumor, and Treatment Characteristics |
| Q94327712 | Omission of whole breast irradiation for postmenopausal women with early breast cancer |
| Q55135169 | Once-Weekly Hypofractionated Radiotherapy for Breast Cancer in Elderly Patients: Efficacy and Tolerance in 486 Patients. |
| Q38397159 | Once-weekly hypofractionated breast irradiation: fool's gold or diamond in the rough? |
| Q37684665 | Oncoplastic surgery and radiation therapy for breast conservation: early outcomes |
| Q33699050 | Optimal approach in early breast cancer: Radiation therapy |
| Q27690879 | Optimal management of breast cancer in the elderly patient: current perspectives |
| Q35684437 | Optimization of Adjuvant Radiation in Breast Conservation Therapy: Can We Minimize without Compromise? |
| Q38792791 | Overview on cardiac, pulmonary and cutaneous toxicity in patients treated with adjuvant radiotherapy for breast cancer |
| Q24193898 | Partial breast irradiation for early breast cancer |
| Q26471072 | Partial breast irradiation for early breast cancer |
| Q38389148 | Patient pathway for breast cancer: turning points and future aspirations. |
| Q46906167 | Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery |
| Q57124865 | Patterns of Practice in Radiotherapy for Breast Cancer in Korea |
| Q36368120 | Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments |
| Q37263260 | Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results |
| Q38220276 | Pneumonitis and pulmonary fibrosis associated with breast cancer treatments. |
| Q41709657 | Possible benefits from post-mastectomy radiotherapy in node-negative breast cancer patients: a multicenter analysis in Korea (KROG 14-22). |
| Q24186275 | Post-mastectomy radiotherapy for breast cancer patients with 1 to 3 positive lymph nodes |
| Q24203952 | Post-mastectomy radiotherapy for breast cancer patients with 1 to 3 positive lymph nodes |
| Q56528378 | Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? |
| Q34655579 | Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up |
| Q37462776 | Primary ectopic breast carcinoma in a supernumerary breast arising in the anterior chest wall: a case report and review of the literature |
| Q38252429 | Progress and controversies: Radiation therapy for prostate cancer |
| Q45212989 | Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop. |
| Q36384305 | Prone breast intensity modulated radiation therapy: 5-year results |
| Q47762552 | Proposal for a gold standard for cosmetic evaluation after breast conserving therapy: Results from the St George and Wollongong Breast Boost trial |
| Q63366125 | Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy |
| Q36365502 | Quality assurance analysis of participating centres' protocol compliance to a UK multicentre hypofractionated breast (FAST) trial |
| Q38741097 | Quantitative Assessment of Breast Cosmetic Outcome After Whole-Breast Irradiation. |
| Q82948148 | Quantitative assessment of irradiated lung volume and lung mass in breast cancer patients treated with tangential fields in combination with deep inspiration breath hold (DIBH) |
| Q41005803 | Racial Disparities in Hypofractionated Radiotherapy Breast Cancer Clinical Trials |
| Q55038620 | Radiation Oncology in the 21st Century: Prospective Randomized Trials That Changed Practice… or Didn't! |
| Q64084078 | Radiation Oncology: A Clinical Update from The North West Cancer Centre |
| Q37413377 | Radiation induced pneumonitis following whole breast radiotherapy treatment in early breast cancer patients treated with breast conserving surgery: a single institution study |
| Q37392375 | Radiation techniques used in patients with breast cancer: Results of a survey in Spain. |
| Q35628076 | Radiation therapy in early-stage invasive breast cancer |
| Q36113697 | Radiation-associated angiosarcoma after breast cancer: high recurrence rate and poor survival despite surgical treatment with R0 resection |
| Q90567425 | Radiobiological parameters for breast cancer: a Monte Carlo analysis of START trial published results |
| Q46342791 | Radioresistance of the breast tumor is highly correlated to its level of cancer stem cell and its clinical implication for breast irradiation |
| Q94704409 | Radiotherapy hypofractionation in early breast cancer |
| Q81668977 | Radiotherapy hypofractionation in early breast cancer |
| Q53137277 | Radiotherapy hypofractionation in early breast cancer. |
| Q34247346 | Radiotherapy in the management of early breast cancer |
| Q37677698 | Radiotherapy issues in elderly breast cancer patients |
| Q36325879 | Radiotherapy physics research in the UK: challenges and proposed solutions. |
| Q84340277 | Radiotherapy. Hypofractionation for breast cancer--clinical implications |
| Q53980225 | Relation between Hypofractionated Radiotherapy, Toxicity and Outcome in Early Breast Cancer. |
| Q37714614 | Release of monocyte migration signals by breast cancer cell lines after ablative and fractionated γ-irradiation. |
| Q42727195 | Reports of unexpected late side effects of accelerated partial breast irradiation--radiobiological considerations. |
| Q35909581 | Results of the First Austrian Multidisciplinary Expert Panel on Controversies in Local Treatment of Breast Cancer |
| Q37266357 | Retrospective Analysis of Efficacy and Toxicity of Hypo-fractionated Radiotherapy in Breast Carcinoma |
| Q27009163 | Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force |
| Q36672778 | STROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics |
| Q47123520 | Short course hypofractionated whole breast irradiation after conservative surgery: a single institution phase II study. |
| Q36202970 | Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial |
| Q55001149 | Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial |
| Q38183438 | Shortened radiation therapy schedules for early-stage breast cancer: a review of hypofractionated whole-breast irradiation and accelerated partial breast irradiation |
| Q35928466 | Similar Outcomes of Standard Radiotherapy and Hypofractionated Radiotherapy Following Breast-Conserving Surgery |
| Q58747161 | Single fraction of accelerated partial breast irradiation in the elderly: early clinical outcome |
| Q36682815 | Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer |
| Q57128759 | Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer |
| Q34708935 | Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: a retrospective analysis of acute skin toxicity and dose inhomogeneities |
| Q35130819 | Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 |
| Q48292905 | Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer |
| Q26795717 | The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation |
| Q48901665 | The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2015 edition |
| Q48661178 | The Japanese Breast Cancer Society clinical practice guideline for radiotherapy of breast cancer |
| Q47946989 | The Royal College of Physicians Simms Lecture, 6 December 2011: clinical research networks and the benefits of intensive healthcare systems |
| Q55299260 | The Screening, Diagnosis, Treatment, and Follow-Up of Breast Cancer. |
| Q36571627 | The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial |
| Q46425805 | The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. |
| Q37719688 | The benefit of adjuvant radiotherapy after breast conserving surgery in older patients with low risk breast cancer- a meta-analysis of randomized trials |
| Q26992321 | The evolution of the locoregional therapy of breast cancer |
| Q47139734 | The long-term outcome of adjuvant hypofractionated radiotherapy and conventional fractionated radiotherapy after breast-conserving surgery for early breast cancer: a prospective analysis of 107 cases |
| Q33843735 | The potential role of three-dimensional surface imaging as a tool to evaluate aesthetic outcome after Breast Conserving Therapy (BCT) |
| Q37863639 | The role of radiation therapy in the control of locoregional and metastatic cancer |
| Q34972167 | The role of radiotherapy-resistant stem cells in breast cancer recurrence |
| Q35125666 | The treatment of early breast cancer in women over the age of 70 |
| Q41713541 | The use of adjuvant radiotherapy in elderly patients with early-stage breast cancer: changes in practice patterns after publication of Cancer and Leukemia Group B 9343. |
| Q89945251 | Three-dimensional surface imaging in breast cancer: a new tool for clinical studies? |
| Q87460937 | Timing of radiotherapy following breast-conserving surgery: outcome of 1393 patients at a single institution |
| Q35588913 | Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer |
| Q33646182 | Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors |
| Q34417188 | Treatment crossovers in time-to-event non-inferiority randomised trials of radiotherapy in patients with breast cancer |
| Q92423416 | Treatment results in patients with ductal carcinoma in situ treated with adjuvant radiotherapy |
| Q52650717 | Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database Analysis. |
| Q97570229 | Tumour response 3 months after neoadjuvant single-fraction radiotherapy for low-risk breast cancer |
| Q37947111 | Ultrashort courses of adjuvant breast radiotherapy: wave of the future or a fool's errand? |
| Q52669834 | Updated ASTRO guidelines on accelerated partial breast irradiation (APBI): to whom can we offer APBI outside a clinical trial? |
| Q34742937 | Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013. |
| Q40382177 | Use of hypofractionated post-mastectomy radiotherapy reduces health costs by over $2000 per patient: An Australian perspective |
| Q31140437 | Use of low-value radiotherapy practices in Canada: an analysis of provincial cancer registry data |
| Q38714617 | Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysis |
| Q39000817 | Utilization trend and regimens of hypofractionated whole breast radiation therapy in the United States. |
| Q38056081 | When are breast cancer patients old enough for the quitclaim of local control? |
| Q31156274 | Whole breast irradiation vs. APBI using multicatheter brachytherapy in early breast cancer - simulation of treatment costs based on phase 3 trial data |
| Q55468519 | Women's Free-text Comments on their Quality of Life: An Exploratory Analysis from the UK Standardisation of Breast Radiotherapy (START) Trials for Early Breast Cancer. |
| Q90004389 | [Whole- or partial-breast radiotherapy after 5 years from a patient perspective: longitudinal analysis of the IMPORT LOW (CRUK/06/003) phase III trial] |
Search more.